PREDICTING THE ADVERSE MATERNAL OUTCOMES IN SUBJECTS WITH PREECLAMPSIA USING THE FULL PIERS MODEL

Abstract

Background: Nearly 10% of all pregnancies in the World present with complications of
hypertensive disorders of pregnancy and preeclampsia. Preeclampsia is also been linked to high mortality rates and near-miss maternal morbidity cases. PIERS or preeclampsia integrated estimate of risk scoring model was made to monitor females with preeclampsia and to assess the risk of stratification which can help in improving the treatment.
Aim: The present clinical study aimed to assess the adverse maternal outcomes in subjects with preeclampsia using the full PIERS model.
Methods: The study assessed female subjects who presented to the institute with preeclampsia and were willing to participate in the study. All the subjects were assessed with a full PIERS calculator in the prediction of the risk for adverse maternal outcomes following the assessment of the variables of prediction.
Results: The total number of obstetric admissions in the institute during the study period was
1669 where preeclampsia was seen in 10% (n=167) of study subjects. The subjects included in
the study were 300 females with preeclampsia and maximum performance in the prediction of
adverse maternal outcomes was seen at a fullPIERS scale of 35. Adverse maternal outcomes
were seen in 36.66% (n=110) of subjects whereas death was seen in 1 subject. The relative risk
in the prediction of adverse maternal outcomes in females with a fullPIERS score of ≥35 was 4.4 with a 95% CI of (2.5-8.2).
Conclusions: The present study concludes that in females with preeclampsia, adverse maternal outcomes are significantly associated with the fullPIERS score of ≥35.